No abstract available
Keywords:
PD-1; anti-angiogenic agent; apatinib; camrelizumab; combination therapy; sarcomatous choledochal carcinoma.
MeSH terms
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Combined Chemotherapy Protocols
-
Carcinoma*
-
Humans
-
Neoplasm Recurrence, Local
-
Sarcoma*
Substances
-
apatinib
-
camrelizumab
-
Antibodies, Monoclonal, Humanized